Dr. Brian Brink advises Anglo American plc Group companies on a broad range of health issues, ranging from occupational health and employee health benefits to health systems strengthening in disadvantaged communities. He has been with the Anglo American Group for over 30 years. Dr. Brink strives to enhance the role of the private sector as a partner in improving access to sustainable, quality healthcare – particularly in developing countries.
Dr. Brink has been actively involved in tackling HIV/AIDS since the beginning of the epidemic. He is responsible for guiding Anglo American’s response to HIV/AIDS and TB, both in the workplace and in communities associated with the company’s operations. Anglo American Group companies sponsor the largest single employer based HIV wellness programs in the world, with 9,000 employees enrolled in HIV care and support, of whom 60% (5,400) currently receive antiretroviral therapy. The company has also invested in several community-based initiatives to prevent the further spread of HIV and to accelerate access to HIV/AIDS and TB testing and treatment. On a broader scale, Dr. Brink is actively involved in addressing the particular challenge the HIV/AIDS and TB epidemics pose to business in Southern Africa and internationally. He also has an active interest in gender issues in relation to HIV and AIDS, particularly the extraordinary vulnerability of young women and girls to HIV infection.
Representing the Private Sector, Dr. Brink has served the board of the Global Fund to fight AIDS, TB and Malaria since the inception of the Fund and was vice-chair of the Fund’s Audit and Ethics Committee for a two year term. Dr Brink is a member of the South African National AIDS Council (SANAC) Trust, which oversees the implementation of the National Strategic Plan for HIV, TB and STI’s. Dr. Brink is an independent director of Discovery Holdings, the largest health insurer in South Africa, with interests in the US, UK and China.